| S74E-R104M-D133A dCK variant in complex with L-deoxythymidine and UDP | |
Heteromer
| 19-260 | 95.8 | 2×UDP; 2×LLT; |
|
| Human dCK C4S-S74E mutant in complex with UDP and the F2.4.1 inhibitor (2-[({2-[3-(2-FLUOROETHOXY)-… | | homo-2-mer | 18-260 | 98.28 | 2×18V; 2×UDP; |
|
| C4S dCK variant of dCK in complex with L-dC+ADP | | homo-2-mer | 19-260 | 98.76 | 2×ADP; 2×LDC; |
|
| Crystal structure of dCK C4S-S74E mutant in complex with UDP and the OR0634 inhibitor | | homo-2-mer | 19-260 | 98.26 | 2×UDP; 2×J29; 2×NA; |
|
| C4S dCK variant of dCK in complex with gemcitabine+ADP | | homo-2-mer | 19-260 | 98.76 | 2×ADP; 2×GEO; |
|
| Crystal structure of dCK C4S-S74E mutant in complex with UDP and the OR0345 inhibitor | | homo-2-mer | 19-260 | 98.26 | 2×UDP; 2×JCM; 2×NA; |
|
| Crystal structure of dCK C4S-S74E mutant in complex with UDP and the OR0624 inhibitor | | homo-2-mer | 19-260 | 98.26 | 2×UDP; 2×J6M; 2×NA; |
|
| The structure of deoxycytidine kinase complexed with lamivudine and ADP. | | homo-2-mer | 19-260 | 98.76 | 2×ADP; 2×3TC; |
|
| Human dCK C4S-S74E mutant in complex with UDP and the F2.2.1 inhibitoR (2-[({2-[3-(2-FLUOROETHOXY)-… | | homo-2-mer | 19-260 | 98.25 | 2×UDP; 4×1NO; |
|
| C4S dCK variant of dCK in complex with FTC+ADP | | homo-2-mer | 19-260 | 98.76 | 2×ADP; 2×ETV; |
|
| Crystal structure of dCK C4S-S74E mutant in complex with UDP and the OR0642 inhibitor | | homo-2-mer | 19-260 | 98.26 | 2×J98; 2×UDP; 2×NA; |
|
| C4S dCK variant of dCK in complex with D-dC+ADP | | homo-2-mer | 19-260 | 98.75 | 2×ADP; 2×DCZ; |
|
| Human dCK complex with 5-Me dC and ADP | | homo-2-mer | 19-260 | 98.7 | 2×ADP; 2×MCY; |
|
| Structure of human dCK complexed with 2'-Deoxycytidine and ADP, Space group C 2 2 21 | | homo-2-mer | 19-260 | 100 | 2×ADP; 2×DCZ; |
|
| Crystal structure of dCK C4S-S74E mutant in complex with UDP and the OR0602 inhibitor | | homo-2-mer | 19-260 | 98.25 | 2×UDP; 2×J5U; 2×NA; |
|
| S74E dCK in complex with 5-bromodeoxycytidine and UDP | | homo-2-mer | 19-260 | 98.31 | 2×UDP; 2×5BT; |
|
| Human dCK C4S-S74E mutant in complex with UDP and the F2.1.1 inhibitor (2-[({2-[3-(2-FLUOROETHOXY)-… | | homo-2-mer | 19-260 | 98.28 | 4×1NM; 2×UDP; |
|
| Crystal structure of dCK C4S-S74E mutant in complex with UDP and the OR0274 inhibitor | | homo-2-mer | 19-260 | 98.25 | 2×UDP; 2×J9I; 2×NA; |
|
| Human dCK C4S-S74E mutant in complex with UDP and the inhibitor 4 [1-[5-(4-{[(2,6-diaminopyrimidin-… | | homo-2-mer | 19-260 | 98.26 | 4×2XJ; 2×UDP; |
|
| Crystal structure of dCK C4S-S74E mutant in complex with UDP and the OR0325 inhibitor | | homo-2-mer | 19-260 | 98.25 | 2×UDP; 2×JAQ; 2×NA; |
|
| Crystal structure of dCK C4S-S74E mutant in complex with EdC and UDP | | homo-2-mer | 19-260 | 98.28 | 2×UDP; 2×VVC; |
|
| The structure of deoxycytidine kinase complexed with troxacitabine and ADP. | | homo-2-mer | 19-260 | 98.76 | 2×ADP; 2×LTT; |
|
| Human dCK C4S-S74E mutant in complex with UDP and the F2.3.1 inhibitor (2-[({5-ETHYL-2-[3-(2-FLUORO… | | homo-2-mer | 19-260 | 98.28 | 3×1NN; 2×UDP; |
|
| Crystal structure of dCK C4S-S74E mutant in complex with UDP and the dCKi2 inhibitor | | homo-2-mer | 19-260 | 98.26 | 2×UDP; 2×J7W; 2×NA; |
|
| S74E-dCK mutant in complex with UDP | | homo-2-mer | 19-260 | 98.29 | 2×UDP; |
|
| C4S-E247A dCK variant of dCK in complex with cladribine+ADP | | homo-2-mer | 19-260 | 98.35 | 2×ADP; 2×CL9; |
|
| Crystal structure of dCK mutant C3S in complex with masitinib and UDP | | homo-2-mer | 19-260 | 99.13 | 2×UDP; 1×G65; 1×DCM; |
|
| Structure of human dCK complexed with cytarabine and ADP-MG | | homo-2-mer | 20-260 | 100.0 | 2×MG; 2×AR3; 2×ADP; |
|
| C4S dCK variant of dCK in complex with D-dA+UDP | | homo-2-mer | 20-260 | 99.08 | 4×UDP; 2×3D1; |
|
| C4S dCK variant of dCK in complex with L-dA+UDP | | homo-2-mer | 20-260 | 99.09 | 2×UDP; 2×3L1; |
|
| C4S dCK variant of dCK in complex with cladribine+UDP | | homo-2-mer | 20-260 | 98.64 | 2×UDP; 2×CL9; |
|
| Human dCK C4S-S74E mutant in complex with UDP and the inhibitor 10 {2-{[(1R/S)-1-{2-[3-(2-fluoroeth… | | homo-2-mer | 20-260 | 98.27 | 2×2Y8; 2×2Y7; 2×UDP; |
|
| Crystal structure of dCK C4S-S74E mutant in complex with UDP and the dCKi1 inhibitor | | homo-2-mer | 20-260 | 98.25 | 2×UDP; 4×JCA; 2×NA; |
|
| Structure of human dCK complexed with gemcitabine and ADP-MG | | homo-2-mer | 20-260 | 100.0 | 2×MG; 2×ADP; 2×GEO; |
|
| Human dCK C4S-S74E mutant in complex with UDP and the inhibitor 6 {2-[5-(4-{[(4,6-diaminopyrimidin-… | | homo-2-mer | 20-260 | 98.26 | 2×2XZ; 2×UDP; |
|
| Human dCK C4S-S74E mutant in complex with UDP and the DI-43 inhibitor | | homo-2-mer | 20-260 | 98.27 | 2×1UX; 2×UDP; |
|
| Crystal structure of dCK C4S-S74E mutant in complex with UDP and the OR0635 inhibitor | | homo-2-mer | 20-260 | 98.25 | 2×UDP; 2×J7I; 2×NA; |
|
| Human dCK C4S-S74E mutant in complex with UDP and the inhibitor 9 {2-{[(1R)-1-{2-[3-(2-fluoroethoxy… | | homo-2-mer | 20-260 | 98.27 | 2×2Y1; 2×UDP; |
|
| Human dCK C4S-S74E mutant in complex with UDP and the inhibitor 8 {2,2'-[{4-[(2R)-4-{[(4,6-diaminop… | | homo-2-mer | 20-260 | 98.26 | 2×2XM; 2×UDP; |
|
| Human dCK C4S-S74E mutant in complex with UDP and the DI-39 inhibitor | | homo-2-mer | 20-260 | 98.26 | 2×1QC; 2×UDP; |
|
| Human dCK C4S-S74E mutant in complex with UDP and the inhibitor 5 {5-(4-{[(4,6-DIAMINOPYRIMIDIN-2-Y… | | homo-2-mer | 20-260 | 98.25 | 2×2XL; 2×UDP; |
|
| Human dCK C4S-S74E mutant in complex with UDP and the inhibitor 12R {N-{2-[5-(4-{(1R)-1-[(4,6-diami… | | homo-2-mer | 20-260 | 98.27 | 2×UDP; 2×2XN; |
|
| Human dCK complex with Acyclic Nucleoside | | homo-2-mer | 20-260 | 98.7 | 2×AC2; 2×UDP; |
|
| C4S dCK variant of dCK in complex with L-dA+ADP | | homo-2-mer | 20-260 | 98.68 | 2×MG; 2×3L1; 2×ADP; |
|
| Human dCK C4S-S74E mutant in complex with UDP and the inhibitor 7 {N-(2-(3-(4-(((4,6-diaminopyrimid… | | homo-2-mer | 20-260 | 98.25 | 2×2Y0; 2×UDP; |
|
| Structure of human dCK complexed with 2'-Deoxycytidine and ADP, P 43 21 2 space group | | homo-2-mer | 20-260 | 100.0 | 2×ADP; 2×DCZ; |
|
| C4S-E247A dCK variant of dCK in complex with D-dA+ADP | | homo-2-mer | 20-260 | 98.34 | 2×ADP; 2×3D1; |
|
| Crystal structure of human dCK R104M/D133A in complex with L-dT and ADP | | homo-2-mer | 20-260 | 99.11 | 2×ADP; 2×LLT; |
|
| Crystal structure of human dCK complexed with clofarabine and ADP | | homo-2-mer | 20-260 | 100.0 | 2×MG; 2×ADP; 2×CFB; |
|
| Crystal Structure of human deoxycytidine kinase in complex with deoxycytidine and uridine diphospha… | | homo-2-mer | 20-260 | 100 | 1×CA; 2×MG; 2×DCZ; 2×UDP; |
|
| Crystal structure of human deoxycytidine kinase in complex with deoxycytidine | | homo-2-mer | 20-260 | 100 | 1×CA; 2×DCZ; |
|
| Crystal structure of dCK mutant C3S in complex with imatinib and UDP | | homo-2-mer | 20-260 | 99.13 | 2×UDP; 1×STI; 1×MG; 1×DCM; |
|
| Human Deoxycytidine kinase dCMP, UDP, Mg ion product complex | | homo-2-mer | 20-260 | 100.0 | 2×MG; 2×UDP; 2×DCM; |
|
| Human Deoxycytidine kinase dAMP, UDP, Mg ion product complex | | homo-2-mer | 20-260 | 100.0 | 2×MG; 2×UDP; 2×D5M; |
|
| Crystal structure of dCK mutant C3S | | homo-2-mer | 20-260 | 99.14 | 2×UDP; 2×UMP; 2×MG; |
|
| C4S dCK variant of dCK in complex with D-dG+UDP | | homo-2-mer | 21-260 | 98.56 | 2×GNG; 2×UDP; |
|
| X-Ray structure of Human Deoxycytidine Kinase in complex with ADP and an inhibitor | | monomer | 20-260 | 100.0 | 1×ADP; 1×B86; 1×MG; |
|
| X-Ray structure of Human Deoxycytidine Kinase in complex with an inhibitor | | monomer | 20-260 | 100.0 | 1×MLT; 2×B87; |
|